Philip Bertucci, MD
Ophthalmology · Gulfport, MSNPI 1194793299
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,740 of the $3,739 with a category attached, or 73.3%. Novartis accounts for 73.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $2,966 and has fallen 92.4% since, to $224 in 2025.
Across 35 payments — averaging $106.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$3K
- Alcon$295
- Johnson & Johnson Surgical Vision, Inc.$151
- Glaukos Corporation$109
- Apellis Pharmaceuticals, Inc.$91
- AbbVie$80
- plus $274 from 8 others
What the payments were for
- Consulting fees$2,74073%
- Food & beverage$99927%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 5 | $2,740 |
| Alcon | 9 | $295 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $151 |
| Glaukos Corporation | 2 | $109 |
| Apellis Pharmaceuticals, Inc. | 1 | $91 |
| AbbVie | 3 | $80 |
| Omeros Corporation | 1 | $79 |
| Rayner Intraocular Lenses Limited | 1 | $50 |
| Bausch & Lomb Americas Inc. | 2 | $43 |
| Dompe US, Inc. | 1 | $33 |
| Indivior Inc. | 1 | $28 |
| Biotissue Holdings Inc. | 1 | $18 |
| Aerie Pharmaceuticals, Inc. | 1 | $13 |
| Quidel Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,739 in reported general payments places this provider in the 70th percentile of 150 ophthalmology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 348 | $17,873 |
| RestasisCyclosporine | 15 | $10,792 |
| LumiganBimatoprost | 17 | $8,767 |
| Latanoprost | 407 | $4,384 |
| Tobramycin | 367 | $2,104 |
| Travoprost | 17 | $1,657 |
| Brimonidine Tartrate | 171 | $1,363 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 100 | $1,284 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 66 | $1,076 |
| Timolol Maleate | 57 | $662 |
| Ketorolac Tromethamine | 13 | $479 |
| Dorzolamide Hcl | 29 | $373 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 165 | $330 |
| ErythromycinErythromycin Base | 12 | $161 |
| Furosemide | 18 | $9 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $80 | $19,55932 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 150 ophthalmology providers in Mississippi.
Other ophthalmology in Gulfport
- Donald BenefieldGulfport$6K
- Kiper NelsonHattiesburg$234K
- John ParkerTupelo$72K
- Joseph ChildsTupelo$42K
- Heather HancockJackson$39K
- Leslie AdenFlowood$38K
- Adam QuinnHattiesburg$29K
- Mark KoskoJackson$27K
- James ShippOxford$21K
- Calvin BrownOlive Branch$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.